What is the clinical appearance of Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The clinical appearance of diabetic ketoacidosis (DKA) is characterized by hyperglycemia, metabolic acidosis, and ketosis, presenting with symptoms such as polyuria, polydipsia, weight loss, and abdominal pain [ 1 ]. Patients may exhibit Kussmaul breathing, a deep and labored breathing pattern, and may have a fruity odor on their breath due to acetone production.

Key Clinical Features

  • Dehydration
  • Altered mental status
  • Hypotension
  • Kussmaul respirations
  • Abdominal pain

Laboratory Findings

  • Elevated blood glucose levels
  • Anion gap metabolic acidosis
  • Elevated ketone bodies, such as beta-hydroxybutyrate [ 1 ]. Physical examination may reveal dehydration, altered mental status, and hypotension. The diagnosis of DKA is typically made based on the presence of hyperglycemia, metabolic acidosis, and ketosis [ 1 ]. The clinical presentation of DKA can vary, but it often includes a history of polyuria, polydipsia, polyphagia, weight loss, vomiting, abdominal pain, dehydration, weakness, clouding of sensoria, and finally coma [ 1 ].

From the Research

Clinical Appearance of Diabetic Ketoacidosis (DKA)

The clinical appearance of DKA can vary, but it is typically characterized by:

  • Hyperglycemia, although euglycemic DKA can also occur 2, 3
  • Metabolic acidosis, with an anion gap and decreased serum bicarbonate levels 4, 3
  • Ketonuria or ketonemia, with elevated beta-hydroxybutyrate levels 2, 5, 3
  • Symptoms such as polyuria, polydipsia, nausea, vomiting, abdominal pain, weight loss, severe fatigue, dyspnea, and preceding febrile illness 4, 5, 3
  • Dehydration, with increased heart and respiratory rates 5
  • Electrolyte imbalances, including decreased phosphate and potassium levels 3

Special Considerations

  • DKA can be masked by euglycemia and primary metabolic alkalosis, making diagnosis more challenging 2
  • Newly diagnosed Type 1 DM patients with DKA may have more severe clinical and biochemical profiles compared to known cases 5
  • The use of sodium-glucose cotransporter-2 inhibitors can increase the risk of DKA and euglycemic DKA 3
  • Patients with DKA can present with a range of symptoms, from mild to severe, and may require close monitoring and aggressive treatment in an intensive care unit or general medical/surgical ward 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.